The power of linked open data — exploiting ligand-transporter interaction profiles

webinar

Tue, 24 May 2016, 16:00 CEST (Berlin)

Prof. Dr. Gerhard F. Ecker

The power of linked open data — exploiting ligand-transporter interaction profiles

With the public availability of large integrated data sources such as the Open PHACTS Discovery Platform, retrieval of data sets for certain protein targets of interest measured under consistent assay conditions is no longer a time consuming process. Especially the use of workflow engines such as KNIME or Pipeline Pilot allows to submit complex queries and enables to simultaneously search for several targets. Data can then directly be used as input to e.g. ChemBioNavigator or SeeSAR for ligand- and structure-based studies. Within this webinar we will present case studies for the development of ligand-transporter interaction models and their use for selectivity profiling.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on